Fehse B - Search Results

1

Loss of CD38 antigen on CD34+CD38+ cells during short-term culture.

von Laer D, Corovic A, Vogt B, Fehse B, Roscher S, Rimek A, Baum C, Ostertag W. von Laer D, et al. Among authors: fehse b. Leukemia. 2000 May;14(5):947-8. doi: 10.1038/sj.leu.2401740. Leukemia. 2000. PMID: 10803533 No abstract available.

2

Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene.

Fehse B, Uhde A, Fehse N, Eckert HG, Clausen J, Rüger R, Koch S, Ostertag W, Zander AR, Stockschläder M. Fehse B, et al. Among authors: fehse n. Hum Gene Ther. 1997 Oct 10;8(15):1815-24. doi: 10.1089/hum.1997.8.15-1815. Hum Gene Ther. 1997. PMID: 9358031

3

Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors.

Hildinger M, Fehse B, Hegewisch-Becker S, John J, Rafferty JR, Ostertag W, Baum C. Hildinger M, et al. Among authors: fehse b. Hum Gene Ther. 1998 Jan 1;9(1):33-42. doi: 10.1089/hum.1998.9.1-33. Hum Gene Ther. 1998. PMID: 9458240

4

Rapid and efficient cloning of proviral flanking fragments by kanamycin resistance gene complementation.

Fehse B, Kühlcke K, Langer A, Ostertag W, Lother H. Fehse B, et al. Nucleic Acids Res. 1999 Jan 15;27(2):706-7. doi: 10.1093/nar/27.2.706. Nucleic Acids Res. 1999. PMID: 9863001 Free PMC article.

5

Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking.

Hildinger M, Schilz A, Eckert HG, Bohn W, Fehse B, Zander A, Ostertag W, Baum C. Hildinger M, et al. Among authors: fehse b. Gene Ther. 1999 Jul;6(7):1222-30. doi: 10.1038/sj.gt.3300942. Gene Ther. 1999. PMID: 10455430

6

Amphotropic and VSV-G-pseudotyped retroviral vectors transduce human hematopoietic progenitor cells with similar efficiency.

von Laer D, Corovic A, Vogt B, Herwig U, Roscher S, Fehse B, Baum C. von Laer D, et al. Among authors: fehse b. Bone Marrow Transplant. 2000 May;25 Suppl 2:S75-9. doi: 10.1038/sj.bmt.1702360. Bone Marrow Transplant. 2000. PMID: 10933195

7

CD34 splice variant: an attractive marker for selection of gene-modified cells.

Fehse B, Richters A, Putimtseva-Scharf K, Klump H, Li Z, Ostertag W, Zander AR, Baum C. Fehse B, et al. Mol Ther. 2000 May;1(5 Pt 1):448-56. doi: 10.1006/mthe.2000.0068. Mol Ther. 2000. PMID: 10933966 Free article.

8

Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell.

Li Z, Fehse B, Schiedlmeier B, Düllmann J, Frank O, Zander AR, Ostertag W, Baum C. Li Z, et al. Among authors: fehse b. Leukemia. 2002 Sep;16(9):1655-63. doi: 10.1038/sj.leu.2402619. Leukemia. 2002. PMID: 12200677

9

Mutagenesis by retroviral transgene insertion: risk assessment and potential alternatives.

Baum C, Fehse B. Baum C, et al. Among authors: fehse b. Curr Opin Mol Ther. 2003 Oct;5(5):458-62. Curr Opin Mol Ther. 2003. PMID: 14601513 Review.

10

Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene.

Loew R, Selevsek N, Fehse B, von Laer D, Baum C, Fauser A, Kuehlcke K. Loew R, et al. Among authors: fehse b. Mol Ther. 2004 May;9(5):738-46. doi: 10.1016/j.ymthe.2004.02.010. Mol Ther. 2004. PMID: 15120335 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page